Lupin`s Generic Tolvaptan Receives Approval in the U.S.
Alkem's Generic Tolvaptan Receives Approval in the U.S.
Apotex's Generic Tolvaptan Receives Approval in the U.S.
Hetero's Generic Tolvaptan Receives Approval in the U.S.
HORSHAM, Pa.--(BUSINESS WIRE)--Palladio Biosciences, Inc. (Palladio), a privately-owned, clinical stage biopharmaceutical company developing medicines for orphan diseases of the kidney, announced today the results of a study that investigated the use of lixivaptan in a patient with autosomal dominant polycystic kidney disease (ADPKD) who could not tolerate a different vasopressin V2 receptor antagonist, tolvaptan. The presentation will be made as an ePoster during the American Society of Nephrology’s Kidney Week 2020. The conference is being held as a fully digital meeting, October 22-25.
Apotex's Generic Tolvaptan Receives Approval in US
Alkem Lab Generic Tolvaptan Receives Approval in US
Alkem Lab`s Generic Tolvaptan Receives Tentative Approval in US
Daiichi-Sankyo, Bayer, Otsuka and Others Called Out for UK Advertisement Breaches
Otsuka Pharmaceutical's Samsca (tolvaptan) Receives Approval in Europe